(Q39579486)

13 September 2017

Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier (English)

1 reference

13 September 2017

0 references

0 references

1 reference

Sneha Avinash Kulkarni

series ordinal

1

1 reference

PubMed ID

21385139

13 September 2017

Si-Shen Feng

series ordinal

2

1 reference

13 September 2017

1 February 2011

1 reference

13 September 2017

1 reference

13 September 2017

6

1 reference

13 September 2017

2

1 reference

13 September 2017

377-394

1 reference

Active targeting of brain tumors using nanocarriers

13 September 2017

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Innovations in design and delivery of chemotherapy for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Nanoparticle technology for drug delivery across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Pluronic block copolymers: novel functional molecules for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Nanoparticles of biodegradable polymers for clinical administration of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Polymer based drug delivery systems for mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Nanoparticulate systems for brain delivery of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Alternative drug formulations of docetaxel: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Paclitaxel nanoparticles for the potential treatment of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

The use of in vitro cell culture models for mechanistic studies and as permeability screens for the blood-brain barrier in the pharmaceutical industry--background and current status in the drug discovery process.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

The Madin Darby canine kidney (MDCK) epithelial cell monolayer as a model cellular transport barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

The uptake and intracellular fate of PLGA nanoparticles in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Characterization of nanoparticle uptake by endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

The role of membrane-bound macromolecules and macromolecules in solution in cell/cell encounters in flowing blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Surface modification of nanoparticles by PEO/PPO block copolymers to minimize interactions with blood components and prolong blood circulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.131

21 January 2018

Identifiers

DOI

10.2217/NNM.10.131

1 reference

release_ktwrnf2orbea5ppqaxmnn7nrni

13 September 2017

0 references

PubMed ID

21385139

1 reference

PubMed ID

21385139